This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Prostate Cancer
and you are
between 20 and 73
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Primary Objective: - To assess the tolerability at global doses Secondary Objectives: - Safety - Pharmacokinetics - Efficacy

Provided treatments

  • Drug: Cabazitaxel (XRP6258)
  • Drug: prednisolone

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01324583. The sponsor of the trial is Sanofi and it is looking for 48 volunteers for the current phase.
Official trial title:
An Open Label, Dose Escalation, Safety and Pharmacokinetics Phase I Study With Cabazitaxel Administered as a 1-hour Intravenous Infusion Every 3 Weeks in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer